The project on the development of new sensitive biomarks for early diagnosis and a better classification of neuroendocrine tumours is well established and running accord to plan. The first patients with NETs have been included in a unique clinical trial with an Oncolytic virus that is only killing the tumour cells and respect normal cells. The results so far look very promising. We expect to get specimens from 35 patients.
Collaboration with Foundation Pequeño Deseo
Invest for Children has collaborated with the Pequeño Deseo Foundation to help fulfill the wishes of children who have been hospitalized for extended periods. These children demonstrate that perseverance and…
see project 
